Dr. Reddy’s Laboratories - Company Snapshot & SWOT Analysis

June 2019 | 25 pages | ID: D7F446049A1EN
NAVADHI Market Research Pvt Ltd

Abstracts

Dr. Reddy’s Laboratories is an India based multinational pharmaceutical company headquartered in Hyderabad. The company manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology products.

For the period of 2014-2018, the company’s revenue increased from INR 135.85 billion to INR 144.36 billion. The average growth for the period was 1.53%.

Domestic Revenues of the Company increased from INR 19.50 bn in 2014 to INR 25.209 bn in 2018. The compound annual growth rate during the same period is 6.63%. While the export revenue of the company during 2014-2018 increased from INR 112.67 bn to INR 119.15 bn. The company witnessed a CAGR growth rate of 1.41% during the same period.

Scope of Dr. Reddy’s Laboratories - Company Snapshot & SWOT Analysis Report

• This report provides detailed information about Dr. Reddy’s Laboratories including value chain analysis, financial performance, business strategy, and SWOT analysis.
• The report identifies the growth drivers and inhibitors for the global pharmaceutical market.
• This report provides information about current and future trends for the global pharmaceutical market.

Contents

1. EXECUTIVE SUMMARY

Scope of Dr. Reddy’s Laboratories - Company Snapshot & SWOT Analysis Report
Research Methodology

2. GROWTH DRIVERS AND INHIBITORS FOR GLOBAL PHARMACEUTICALS MARKET

3. COMPANY PROFILE

3.1 Dr. Reddy’s Laboratories
  3.1.1 Company Profile
  3.1.2 Dr. Reddy’s Laboratories in Pharma Manufacturing Value Chain
  3.1.3 Dr. Reddy’s Laboratories: Financial Performance
  3.1.4 Dr. Reddy’s Laboratories: Business Strategy
    3.1.4.1 Product Level Business Strategy
    3.1.4.2 Service Level Business Strategy
  3.1.5 SWOT Analysis of Dr. Reddy’s Laboratories
    Strengths
    Weaknesses
    Opportunities
    Threats

4. CURRENT AND FUTURE TRENDS IN PHARMACEUTICAL MARKET

Orphan Drugs
Biologics and Biosimilars
Current Trends

1. INCREASING SEVERITY OF DRUG PRICE CONTROLS

2. GREATER FOCUS ON RARE DISEASES / ORPHAN DRUGS

3. INCREASING DEVELOPMENT OF NUCLEIC ACIDS AS THERAPEUTICS

4. INCREASING FOCUS ON CELL THERAPY

5. IMPLANTABLES (BIOELECTRONICS) AND ELECTROCEUTICALS ARE EXPECTED TO BECOME MAINSTREAM

6. USE OF 3D PRINTING TO REDUCE COST AND IMPROVE PRODUCTION EFFICIENCY OF BIOLOGICS

7. INCREASING USE OF BIG DATA AND ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY

Notes
Company Information

List Of Exhibits

LIST OF EXHIBITS

Exhibit 2.1 Growth Drivers and Inhibitors for Global Pharmaceuticals Market
Exhibit 3.1 Key Information of Dr. Reddy’s Laboratories
Exhibit 3.2 Contact Information of Dr. Reddy’s Laboratories
Exhibit 3.3 Dr. Reddy’s Laboratories in Pharmaceuticals Manufacturing Value Chain
Exhibit 3.4 Dr. Reddy’s Laboratories Revenue 2013-2018 (in INR million)
Exhibit 3.5 Year-wise Dr. Reddy’s Laboratories Revenue Growth 2014-18 (in %)
Exhibit 3.6 Dr. Reddy’s Laboratories Domestic Revenue 2014-2018 (in INR billion)
Exhibit 3.7 Year-wise Dr. Reddy’s Laboratories Domestic Revenue Growth 2015-2018 (in %)
Exhibit 3.8 Dr. Reddy’s Laboratories Export Revenue 2014-2018 (in INR billion)
Exhibit 3.9 Year-wise Dr. Reddy’s Laboratories Export Revenue Growth 2015-2017 (in %)
Exhibit 3.10 Source wise Revenue share of Dr. Reddy’s Lab. (in %)
Exhibit 3.11 Source wise Revenue CAGR growth forecast for Dr. Reddy’s Lab Ltd. 2019-23 (in %)
Exhibit 3.12 Forecast of Dr. Reddy’s Laboratories Ltd, 2018-23 (in INR bn)
Exhibit 3.13 Growth forecast of Domestic Revenue for Dr. Roddy’s Laboratories Ltd. 2018-23 (in INR bn)
Exhibit 3.14 Growth forecast of Export revenue for Dr. Reddy’s Laboratories ltd. Market 2018-23 (in INR bn)
Exhibit 3.15 Key Products of Dr. Reddy’s Laboratories
Exhibit 3.16 Key Services of Dr. Reddy’s Laboratories
Exhibit 3.17 SWOT Analysis of Dr. Reddy’s Laboratories